Latest Insider Transactions at Unitedhealth Group Inc (UNH)
This section provides a real-time view of insider transactions for Unitedhealth Group Inc (UNH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of UNITEDHEALTH GROUP INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of UNITEDHEALTH GROUP INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2024
|
John F Rex President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
76
+0.05%
|
-
|
|
Jun 25
2024
|
John H Noseworthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
22
+0.44%
|
-
|
|
Jun 25
2024
|
Erin Mc Sweeney EVP & Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25
+0.27%
|
-
|
|
Jun 25
2024
|
Stephen J Hemsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
28
+0.0%
|
-
|
|
Jun 25
2024
|
Frederick William Mcnabb Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
28
+0.22%
|
-
|
|
Jun 25
2024
|
Brian R Thompson CEO, UnitedHealthcare |
BUY
Grant, award, or other acquisition
|
Direct |
44
+0.13%
|
-
|
|
Jun 25
2024
|
Charles D. Baker Director |
BUY
Grant, award, or other acquisition
|
Direct |
2
+0.68%
|
-
|
|
Jun 14
2024
|
Stephen J Hemsley Director |
SELL
Payment of exercise price or tax liability
|
Direct |
214,186
-6.43%
|
$106,236,256
$496.76 P/Share
|
|
Jun 14
2024
|
Stephen J Hemsley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
332,148
+9.0%
|
$63,108,120
$190.27 P/Share
|
|
Jun 07
2024
|
Heather Cianfrocco Chief Executive Officer, Optum |
SELL
Payment of exercise price or tax liability
|
Direct |
212
-1.25%
|
$103,880
$490.69 P/Share
|
|
Jun 07
2024
|
Brian R Thompson CEO, UnitedHealthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
259
-0.79%
|
$126,910
$490.69 P/Share
|
|
Jun 07
2024
|
Erin Mc Sweeney EVP & Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
128
-1.36%
|
$62,720
$490.69 P/Share
|
|
Jun 06
2024
|
Stephen J Hemsley Director |
SELL
Bona fide gift
|
Direct |
7,850
-1.12%
|
-
|
|
Jun 05
2024
|
Heather Cianfrocco Chief Executive Officer, Optum |
SELL
Payment of exercise price or tax liability
|
Direct |
295
-1.7%
|
$148,385
$503.12 P/Share
|
|
Jun 03
2024
|
Heather Cianfrocco Chief Executive Officer, Optum |
BUY
Grant, award, or other acquisition
|
Direct |
252
+1.43%
|
-
|
|
Jun 03
2024
|
John F Rex President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
302
+0.18%
|
-
|
|
Apr 01
2024
|
Stephen J Hemsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
291
+0.05%
|
-
|
|
Apr 01
2024
|
Michele J Hooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
115
+0.29%
|
-
|
|
Apr 01
2024
|
John H Noseworthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
192
+3.73%
|
-
|
|
Apr 01
2024
|
Frederick William Mcnabb Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
196
+1.51%
|
-
|
|
Apr 01
2024
|
Gil Kristen Director |
BUY
Grant, award, or other acquisition
|
Direct |
179
+9.12%
|
-
|
|
Apr 01
2024
|
Paul R Garcia Director |
BUY
Grant, award, or other acquisition
|
Direct |
179
+4.88%
|
-
|
|
Apr 01
2024
|
Charles D. Baker Director |
BUY
Grant, award, or other acquisition
|
Direct |
179
+38.17%
|
-
|
|
Apr 01
2024
|
Rice Valerie Md Montgomery Director |
BUY
Grant, award, or other acquisition
|
Direct |
192
+3.4%
|
-
|
|
Apr 01
2024
|
Timothy Patrick Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
192
+1.93%
|
-
|
|
Mar 19
2024
|
John F Rex President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
67
+0.04%
|
-
|
|
Mar 19
2024
|
Thomas E Roos Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.05%
|
-
|
|
Mar 19
2024
|
Michele J Hooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
135
+0.35%
|
-
|
|
Mar 19
2024
|
Paul R Garcia Director |
BUY
Grant, award, or other acquisition
|
Direct |
4
+0.11%
|
-
|
|
Mar 19
2024
|
Brian R Thompson CEO, UnitedHealthcare |
BUY
Grant, award, or other acquisition
|
Direct |
41
+0.12%
|
-
|
|
Mar 19
2024
|
Dirk C Mc Mahon President & COO, UHG |
BUY
Grant, award, or other acquisition
|
Direct |
41
+0.06%
|
-
|
|
Mar 19
2024
|
Timothy Patrick Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
31
+0.32%
|
-
|
|
Mar 19
2024
|
Charles D. Baker Director |
BUY
Grant, award, or other acquisition
|
Direct |
1
+0.89%
|
-
|
|
Mar 19
2024
|
Rice Valerie Md Montgomery Director |
BUY
Grant, award, or other acquisition
|
Direct |
19
+0.36%
|
-
|
|
Mar 19
2024
|
Andrew Witty CEO, UHG |
BUY
Grant, award, or other acquisition
|
Direct |
99
+0.1%
|
-
|
|
Mar 19
2024
|
Gil Kristen Director |
BUY
Grant, award, or other acquisition
|
Direct |
2
+0.27%
|
-
|
|
Mar 19
2024
|
Erin Mc Sweeney EVP & Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23
+0.24%
|
-
|
|
Mar 19
2024
|
Frederick William Mcnabb Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
24
+0.19%
|
-
|
|
Mar 19
2024
|
John H Noseworthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
19
+0.4%
|
-
|
|
Mar 19
2024
|
Stephen J Hemsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
24
+0.0%
|
-
|
|
Mar 19
2024
|
Rupert M Bondy EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21
+0.22%
|
-
|
|
Mar 08
2024
|
Erin Mc Sweeney EVP & Chief People Officer |
SELL
Open market or private sale
|
Direct |
1,236
-11.66%
|
$596,988
$483.48 P/Share
|
|
Feb 23
2024
|
Thomas E Roos Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
858
-2.59%
|
$450,450
$525.79 P/Share
|
|
Feb 23
2024
|
Thomas E Roos Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
145
-0.44%
|
$76,415
$527.24 P/Share
|
|
Feb 23
2024
|
Dirk C Mc Mahon President & COO, UHG |
SELL
Payment of exercise price or tax liability
|
Direct |
618
-0.87%
|
$325,686
$527.24 P/Share
|
|
Feb 23
2024
|
Rupert M Bondy EVP & Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
278
-2.82%
|
$146,506
$527.24 P/Share
|
|
Feb 23
2024
|
Andrew Witty CEO, UHG |
SELL
Payment of exercise price or tax liability
|
Direct |
1,212
-1.24%
|
$638,724
$527.24 P/Share
|
|
Feb 23
2024
|
Brian R Thompson CEO, UnitedHealthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
470
-1.41%
|
$247,690
$527.24 P/Share
|
|
Feb 23
2024
|
Erin Mc Sweeney EVP & Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
203
-1.88%
|
$106,981
$527.24 P/Share
|
|
Feb 23
2024
|
John F Rex President & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
669
-0.4%
|
$352,563
$527.24 P/Share
|